These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23920371)

  • 21. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
    Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
    Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.
    Yu J; Jiang C; Xu G
    Am J Ophthalmol; 2014 Oct; 158(4):752-756.e2. PubMed ID: 24973608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choroidal vessel diameter in central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
    Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
    Shin YU; Lee BR
    Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.
    Yang J; Wang E; Yuan M; Chen Y
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study.
    Schwartz R; Habot-Wilner Z; Martinez MR; Nutman A; Goldenberg D; Cohen S; Shulman S; Guzner-Gur H; Loewenstein A; Goldstein M
    Acta Ophthalmol; 2017 Nov; 95(7):e610-e618. PubMed ID: 28653813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pachychoroid Spectrum Disease: Comparison of Patients with Central Serous Chorioretinopathy Complicated with Pachychoroid Neovasculopathy.
    Jung H; Suh Y; Lee J; Lee CS; Kim M; Byeon SH; Kim SS; Kang HG
    Korean J Ophthalmol; 2024 Aug; 38(4):304-315. PubMed ID: 39013560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
    Kim GA; Rim TH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
    Eye (Lond); 2015 Jun; 29(6):732-40; quiz 741. PubMed ID: 25952951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.
    Li M; Qu J; Liang Z; Tang J; Hu J; Yao Y; Jin E; Li X; Zhao M
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2175-2182. PubMed ID: 35024912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundus autofluorescence in acute and chronic central serous chorioretinopathy.
    Dinc UA; Tatlipinar S; Yenerel M; Görgün E; Ciftci F
    Clin Exp Optom; 2011 Sep; 94(5):452-7. PubMed ID: 21480989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Chronic Central Serous Chorioretinopathy with Oral Methotrexate.
    Abrishami M; Mousavi M; Hosseini SM; Norouzpour A
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):468-75. PubMed ID: 26172430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography.
    Ojima Y; Hangai M; Sasahara M; Gotoh N; Inoue R; Yasuno Y; Makita S; Yatagai T; Tsujikawa A; Yoshimura N
    Ophthalmology; 2007 Dec; 114(12):2197-207. PubMed ID: 17507096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.
    Nakamura T; Ueda-Consolvo T; Oiwake T; Hayashi A
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Serous Retinal Detachment on the Measurement of Axial Length in Central Serous Chorioretinopathy.
    Shin YI; Won YK; Shin KS; Jo YJ; Kim JY
    Korean J Ophthalmol; 2019 Feb; 33(1):63-69. PubMed ID: 30746913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY.
    Pertl L; Haas A; Hausberger S; Pichler T; Rabensteiner DF; Seidel G; Malle EM; Weger M
    Retina; 2017 Sep; 37(9):1792-1796. PubMed ID: 27941529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.
    Park YG; Kang S; Kim M; Yoo N; Roh YJ
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1375-1383. PubMed ID: 28421342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
    Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy.
    Zola M; Daruich A; Matet A; Mantel I; Behar-Cohen F
    Br J Ophthalmol; 2019 Aug; 103(8):1184-1189. PubMed ID: 30355720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.